Clinical significance of HIV-associated bone loss: when and how to intervene

Author： Yin Michael T   Shane Elizabeth   Anastos Kathryn  

Publisher： Future Medicine

ISSN： 1746-9600

Source： Future HIV Therapy, Vol.2, Iss.5, 2008-09, pp. : 465-478

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

When to Start Antiretroviral Therapy in HIV-Associated Tuberculosis

By  

Current Respiratory Medicine Reviews, Vol. 9, Iss. 3, 2013-06 ,pp. : 193-199

Bentham Science Publishers

Access to resources Recommend Favorite

HIV-associated dementia: clinical, epidemiological and resource utilization issues

By Starace F.   Dijkgraaf M.   Houweling H.   Postma M.   Tramarin A.  

AIDS Care, Vol. 10, Iss. 2, 1998-06 ,pp. : 113-121

Routledge Ltd

Access to resources Recommend Favorite

Diagnosis and treatment of HIV-associated nephropathy

By Betjes M.G.H.   Weening J.   Krediet R.T.  

The Netherlands Journal of Medicine, Vol. 59, Iss. 3, 2001-09 ,pp. : 111-117

Elsevier

Access to resources Recommend Favorite

Cost consequences of HIV-associated lipoatrophy

By Hornberger J.   Rajagopalan R.   Shewade A.   Loutfy M. R.  

AIDS Care, Vol. 21, Iss. 5, 2009-05 ,pp. : 664-671

Routledge Ltd

Access to resources Recommend Favorite

HIV-Associated Multiple Intracerebral Hemorrhages

By  

European Neurology, Vol. 53, Iss. 2, 2005-05 ,pp. : 100-102

Karger

Access to resources Recommend Favorite